PON1 and myeloid sarcoma: Thus, despite PON1 being a marker sensitive to anthropometric and metabolic improvements after nutritional treatment in MS patients, [48] and that its antioxidant activity is low in the disease [12], it is not a good marker for oxidative stress associated to inflammation for this disease, coinciding with what has been observed by other authors [49].